Diagnostic Performance of MRI using Extracellular Contrast Agents Versus Gadoxetic Acid for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis

2021 ◽  
Author(s):  
Zhichao Feng ◽  
Huafei Zhao ◽  
Shiwei Guan ◽  
Wei Wang ◽  
Pengfei Rong
Keyword(s):  
Hepatocellular Carcinoma ◽  
Systematic Review ◽  
Contrast Agents ◽  
Diagnostic Performance ◽  
Meta Analysis ◽  
Gadoxetic Acid

Diagnostic Performance of CT/MRI Liver Imaging Reporting and Data System v2017 for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis

2020 ◽  
Vol 40 (6) ◽  
pp. 1488-1497 ◽  
Author(s):  
Sunyoung Lee ◽  
Seung‐Seob Kim ◽  
Yun Ho Roh ◽  
Jin‐Young Choi ◽  
Mi‐Suk Park ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Systematic Review ◽  
Diagnostic Performance ◽  
Meta Analysis ◽  
Data System ◽  
Liver Imaging

scholarly journals Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging—A Systematic Review and Meta-Analysis

Radiology ◽  
2015 ◽  
Vol 275 (1) ◽  
pp. 97-109 ◽  
Author(s):  
Yoon Jin Lee ◽  
Jeong Min Lee ◽  
Ji Sung Lee ◽  
Hwa Young Lee ◽  
Bo Hyun Park ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Systematic Review ◽  
Mr Imaging ◽  
Diagnostic Performance ◽  
Multidetector Ct ◽  
Meta Analysis

Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis

2016 ◽  
Vol 45 (1) ◽  
pp. 281-290 ◽  
Author(s):  
Joanna K. Duncan ◽  
Ning Ma ◽  
Thomas D. Vreugdenburg ◽  
Alun L. Cameron ◽  
Guy Maddern
Keyword(s):  
Hepatocellular Carcinoma ◽  
Systematic Review ◽  
Meta Analysis ◽  
Gadoxetic Acid ◽  
Enhanced Mri

miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers

2020 ◽  
Vol 14 (15) ◽  
pp. 1485-1500
Author(s):  
Lichao Yang ◽  
Chunmeng Wei ◽  
Yasi Li ◽  
Xiao He ◽  
Min He
Keyword(s):  
Hepatocellular Carcinoma ◽  
Systematic Review ◽  
Survival Analysis ◽  
Sensitivity And Specificity ◽  
Poor Prognosis ◽  
Early Stage ◽  
Meta Analysis ◽  
Benign Lesion ◽  
Diagnostic Efficiency ◽  
Low Expression

Aim: The aim was to systematically investigate the miRNA biomarkers for early diagnosis of hepatocellular carcinoma (HCC). Materials & methods: A systematic review and meta-analysis of miRNA expression in HCC were performed. Results: A total of 4903 cases from 30 original studies were comprehensively analyzed. The sensitivity and specificity of miR-224 in discriminating early-stage HCC patients from benign lesion patients were 0.868 and 0.792, which were superior to α-fetoprotein. Combined miR-224 with α-fetoprotein, the sensitivity and specificity were increased to 0.882 and 0.808. Prognostic survival analysis showed low expression of miR-125b and high expression of miR-224 were associated with poor prognosis. Conclusion: miR-224 had a prominent diagnostic efficiency in early-stage HCC, with miR-224 and miR-125b being valuable in the prognostic diagnosis.

Sign in / Sign up

Export Citation Format

Share Document